Correlation Between Neurocrine Biosciences and Creative Edge

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Creative Edge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Creative Edge into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Creative Edge Nutrit, you can compare the effects of market volatilities on Neurocrine Biosciences and Creative Edge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Creative Edge. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Creative Edge.

Diversification Opportunities for Neurocrine Biosciences and Creative Edge

0.0

Correlation Coefficient

Neurocrine Biosciences  Creative Edge

Pay attention - limited upside

The 3 months correlation between Neurocrine and Creative is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Creative Edge Nutrit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Creative Edge Nutrit and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Creative Edge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Creative Edge Nutrit has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Creative Edge go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Creative Edge

If you would invest  12,225  in Neurocrine Biosciences on September 16, 2024 and sell it today you would earn a total of  445.00  from holding Neurocrine Biosciences or generate 3.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Neurocrine Biosciences  vs.  Creative Edge Nutrit

Neurocrine Biosciences

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Creative Edge Nutrit

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Creative Edge Nutrit has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Creative Edge is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Neurocrine Biosciences and Creative Edge

The main advantage of trading using opposite Neurocrine Biosciences and Creative Edge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Creative Edge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creative Edge will offset losses from the drop in Creative Edge's long position.

The idea behind Neurocrine Biosciences and Creative Edge Nutrit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.